BOSTON - A pharmaceutical expert witness says the New England Compounding Center failed repeatedly in multiple categories to meet standards for the production of sterile drugs, thus putting patients at grave risk.Eric S. Kastango, a pharmacist who was hired by federal prosecutors to assist in the investigation of the 2012 fungal meningitis outbreak, said, "The testing was not being done. Every time a lot was done, each and every one should have been tested."When drugs that are [...]
↧